Home/Filings/4/0001011034-09-000093
4//SEC Filing

KEMPF DAVID A 4

Accession 0001011034-09-000093

CIK 0001443062other

Filed

Jul 22, 8:00 PM ET

Accepted

Jul 23, 1:09 PM ET

Size

14.1 KB

Accession

0001011034-09-000093

Insider Transaction Report

Form 4
Period: 2009-04-15
KEMPF DAVID A
DirectorCOO/CFO
Transactions
  • Award

    warrants

    2009-04-15$1.50/sh+2,500$3,750309,167 total
    Exercise: $1.50From: 2009-04-15Exp: 2010-10-15common stock (2,500 underlying)
Holdings
  • common stock

    2,500
  • options

    Exercise: $1.00From: 2010-02-11Exp: 2019-02-11common stock (100,000 underlying)
    100,000
  • Series A Convertible Preferred Stock

    Exercise: $0.75From: 2009-06-17common stock (10,000 underlying)
    319,167
  • options

    Exercise: $1.00From: 2012-02-11Exp: 2019-02-11common stock (100,000 underlying)
    300,000
  • warrants

    Exercise: $1.50From: 2009-06-17Exp: 2010-12-17common stock (3,750 underlying)
    322,917
  • common stock

    (indirect: By IRA)
    3,000
  • options

    Exercise: $1.00From: 2011-02-11Exp: 2019-02-11common stock (100,000 underlying)
    200,000
  • Series A Convertible Preferred Stock

    Exercise: $0.75From: 2009-04-15common stock (6,667 underlying)
    306,667
Footnotes (1)
  • [F1]not applicable

Issuer

BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC

CIK 0001443062

Entity typeother

Related Parties

1
  • filerCIK 0001458510

Filing Metadata

Form type
4
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 1:09 PM ET
Size
14.1 KB